Digestive Diseases and Sciences

, Volume 25, Issue 10, pp 763–768

Prevalence of subclinical hepatic encephalopathy in cirrhotics and relationship to plasma amino acid imbalance

  • Giulio Marchesini
  • Marco Zoli
  • Cristina Dondi
  • Lucia Cecchini
  • Angela Angiolini
  • Francesco B. Bianchi
  • Emilio Pisi
Original Articles

Abstract

Neuropsychological status, as assessed by trailmaking test; plasma amino acids, and ammonia, were studied in 54 cirrhotics without clinical evidence of encephalopathy to determine the prevalence of subclinical mental dysfunction and its relationship to metabolic abnormalities. Control values for psychometric performance were established in 54 normal subjects matched for age, sex, educational level, and employment status. Of these subjects, 16 were also used as controls for fasting ammonia and plasma amino acids. Eighteen cirrhotics (33%) showed impaired performances of the psychometric test; free tryptophan and the ratio free tryptophan to neutral amino acids were increased in 37% and 62% of cases and correlated with the psychometric scores (r=0.45 andr=0.70, respectively). In eight cirrhotics with mild encephalopathy, psychometric and metabolic evaluations were repeated several times during the infusion of amino acid solutions rich in branched-chain amino acids. Again significant correlations were observed between the psychometric scores and plasma amino acids. We conclude that a considerable proportion of clinically normal cirrhotics have neuropsychological deficits. The severity of impairment may be related to the plasma amino acid imbalance, namely to an increased passage of tryptophan across the blood-brain barrier.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Conn HO: Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy. Am J Dig Dis 22:541–550, 1977Google Scholar
  2. 2.
    Lam KC, Tall AR, Goldstein GB, Mistilis SP: Role of a false neurotransmitter, octopamine, in the pathogenesis of hepatic and renal encephalopathy. Scand J Gastroenterol 8:465–472, 1973Google Scholar
  3. 3.
    Smith HH, Jr, Smith LS: WAIS functioning of cirrhotic and non-cirrhotic alcoholics. J Clin Psychol 33:309–313, 1977Google Scholar
  4. 4.
    Gilberstadt S, Gilberstadt H, Buegel B, Collier R, McClain CJ, Zieve L: Defective intellectual function in alcoholic cirrhotics and noncirrhotic alcoholics: Relationship to severity of liver disease. Gastroenterology 74:1037, 1978Google Scholar
  5. 5.
    Rehnstrom S, Simert G, Hansson JA, Johnson G, Vang J: Chronic hepatic encephalopathy. A psychometrical study. Scand J Gastroenterol 12:305–311, 1977Google Scholar
  6. 6.
    Rikkers L, Jenko P, Rudman D, Freides D: Subclinical hepatic encephalopathy: Detection, prevalence, and relationship to nitrogen metabolism. Gastroenterology 75:462–469, 1978Google Scholar
  7. 7.
    Zieve L: Hepatic encephalopathy: Summary of present knowledge with an elaboration on recent developments.In Progress in Liver Diseases, Vol VI, H Popper, F Schaffner (eds). New York, Grune & Stratton, 1979, pp 327–341Google Scholar
  8. 8.
    McDermott WW: The role of ammonia intoxication in hepatic coma. Bull NY Acad Med 34:352–365, 1958Google Scholar
  9. 9.
    Fischer JE, Baldessarini RJ: Pathogenesis and therapy of hepatic coma.In Progress in Liver Diseases, Vol V, H Popper, F Schaffner (eds). New York, Grune & Stratton, 1976, pp 363–397Google Scholar
  10. 10.
    Picchiotti R, Bandiera G, Capocaccia L, Attili AF, Donini G, Barnabei A, Panchieri P, Mosticoni R: Portosystemic encephalopathy in cirrhotic patients following portocaval shunt. Quantitative evaluation of neuropsychiatric damage. Ital J Gastroenterol 11:15–20, 1979Google Scholar
  11. 11.
    Cangiano C, Calcaterra V, Cascino A, Rossi-Fanelli F, Capocaccia L: The role of the false neurotransmitters, octopamine and phenylethanolamine, in human hepatic encephalopathy. Rendic Gastroenterol 9:189–193, 1977Google Scholar
  12. 12.
    Dodsworth JM, James JH, Cummings MG, Fischer JE: Depletion of brain norepinephrine in acute hepatic coma. Surgery 75:811–820, 1974Google Scholar
  13. 13.
    Jequier E, Lovenberg W, Sjoersma A: Tryptophan hydroxilase inhibition: The mechanism by whichp-chlorophenylalanine depletes rat brain serotonin. Mol Pharmacol 3:274–299, 1967Google Scholar
  14. 14.
    Baldessarini RJ, Karobath M: Biochemical physiology of central synapsis. Annu Rev Physiol 35:273–304, 1973Google Scholar
  15. 15.
    James JH, Hodgman JM, Funovics JM, Yoshimura M, Fischer JE: Brain tryptophan, plasma free tryptophan, and distribution of plasma neutral amino acids. Metabolism 25:471–476, 1976Google Scholar
  16. 16.
    Cascino A, Cangiano C, Calcaterra V, Rossi-Fanelli F, Capocaccia L: Plasma amino acid imbalance in patients with liver disease. Am J Dig Dis 23:591–598, 1978Google Scholar
  17. 17.
    Marchesini G, Forlani G, Zoli M, Angiolini A, Scolari MP, Bianchi FB, Pisi E: Insulin and glucagon levels in liver cirhosis: Relationship with the plasma amino acid imbalance of chronic hepatic encephalopathy. Dig Dis Sci 24:594–601, 1979Google Scholar
  18. 18.
    Reitan RM: The relation of the trailmaking test to organic brain damage. J Consult Psychol 19:393–405, 1955Google Scholar
  19. 19.
    Davidson EA, Summerskill WHJ: Psychiatric aspects of liver disease. Postgrad Med J 32:487–502, 1956Google Scholar
  20. 20.
    Fischer JE, Funovics JM, Aguirre A, James JH, Keane JM, Wesdorp RIC, Yoshimura N, Westman T: The role of plasma amino acids in hepatic encephalopathy. Surgery 78:276–290, 1975Google Scholar
  21. 21.
    Marchesini G, Forlani G, Angiolini A, Zoli M, Scolari MP, Bianchi FB, Pisi E: Oral glucose in cirrhotics. Effects on plasma amino acid patterns and the role of insulin and glucagon. Diabetes Metab 5:135–139, 1979Google Scholar
  22. 22.
    Seligson D, Hirahara K: The measurement of ammonia in whole blood, erythrocytes and plasma. J Lab Clin Med 49:962–974, 1957Google Scholar
  23. 23.
    Zeegen R, Drinkwater JE, Dawson AM: Methods of measuring cerebral dysfunction in patients with liver disease. Br Med J 2:633–636, 1970Google Scholar
  24. 24.
    Cangiano C, Calcaterra V, Cascino A, Capocaccia L: Bound and free tryptophan plasma levels in hepatic encephalopathy. Rendic Gastroenterol 8:186–189, 1976Google Scholar
  25. 25.
    Ono J, Hutson DG, Dombro RS, Levi JU, Livingstone A, Zeppa R: Tryptophan and hepatic coma. Gastroenterology 74:196–200, 1978Google Scholar
  26. 26.
    Rosen HM, Yoshimura N, Hodgman JM, Fischer JE: Plasma amino acid patterns in hepatic encephalopathy of differing etiology. Gastroenterology 72:483–487, 1977Google Scholar
  27. 27.
    Marchesini G, Zoli M, Cecchini L, Dondi C, Bianchi FB, Pisi E: The number-connection test and plasma amino acid profile in the aseessment of subclinical or mild encephalopathy in liver cirrhosis. Proceedings of the 14th Meeting of the European Association for the Study of the Liver (EASL), Düsseldorf, West Germany, Graefelfing, Demeter, 1979, p 57Google Scholar
  28. 28.
    James JH, Jeppson B, Ziparo V, Fischer JE: Hyperammonaemia, plasma amino acid imbalance, and blood-brain amino acid transport: A unified theory of portal-systemic encephalopathy. Lancet 2:772–775, 1979Google Scholar

Copyright information

© Digestive Disease Systems, Inc. 1980

Authors and Affiliations

  • Giulio Marchesini
    • 1
  • Marco Zoli
    • 1
  • Cristina Dondi
    • 1
  • Lucia Cecchini
    • 1
  • Angela Angiolini
    • 1
  • Francesco B. Bianchi
    • 1
  • Emilio Pisi
    • 1
  1. 1.Istituto di Patologia Medica 1University of BolognaBolognaItaly

Personalised recommendations